GENinCode (LON:GENI – Get Free Report) announced its earnings results on Tuesday. The company reported GBX (1.19) earnings per share for the quarter, Digital Look Earnings reports. GENinCode had a negative net margin of 228.70% and a negative return on equity of 289.74%.
GENinCode Stock Performance
LON:GENI opened at GBX 4 on Tuesday. The stock has a market cap of £11.48 million, a P/E ratio of -158.10 and a beta of 0.66. The firm’s fifty day simple moving average is GBX 2.07 and its 200 day simple moving average is GBX 2.13. GENinCode has a twelve month low of GBX 1 and a twelve month high of GBX 8.50. The company has a quick ratio of 15.89, a current ratio of 2.60 and a debt-to-equity ratio of 9.28.
GENinCode Company Profile
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.
See Also
- Five stocks we like better than GENinCode
- What is diluted earnings per share (Diluted EPS)?
- Dividend Growth Continues as 3 Big Stocks Raise Payouts
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Qualcomm Is on Its Biggest Uptrend in 2 Years—Can It Continue?
- Why Are Stock Sectors Important to Successful Investing?
- Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
